Cresco Labs Inc. (FRA:6CQ)

Cresco Labs Statistics

Total Valuation

Cresco Labs has a market cap or net worth of EUR 256.92 million. The enterprise value is 640.15 million.

Market Cap	256.92M
Enterprise Value	640.15M

Important Dates

The next estimated earnings date is Thursday, March 12, 2026.

Earnings Date	Mar 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	339.77M
Shares Outstanding	n/a
Shares Change (YoY)	+2.55%
Shares Change (QoQ)	+0.33%
Owned by Insiders (%)	2.11%
Owned by Institutions (%)	3.83%
Float	333.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.46
PB Ratio	0.89
P/TBV Ratio	n/a
P/FCF Ratio	6.61
P/OCF Ratio	4.02
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.92, with an EV/FCF ratio of 16.46.

EV / Earnings	-14.39
EV / Sales	1.13
EV / EBITDA	4.92
EV / EBIT	9.23
EV / FCF	16.46

Financial Position

The company has a current ratio of 2.49, with a Debt / Equity ratio of 1.71.

Current Ratio	2.49
Quick Ratio	0.90
Debt / Equity	1.71
Debt / EBITDA	3.82
Debt / FCF	12.73
Interest Coverage	1.39

Financial Efficiency

Return on equity (ROE) is -14.36% and return on invested capital (ROIC) is 5.12%.

Return on Equity (ROE)	-14.36%
Return on Assets (ROA)	3.80%
Return on Invested Capital (ROIC)	5.12%
Return on Capital Employed (ROCE)	6.84%
Revenue Per Employee	194,447
Profits Per Employee	-15,339
Employee Count	2,900
Asset Turnover	0.50
Inventory Turnover	3.73

Taxes

In the past 12 months, Cresco Labs has paid 38.73 million in taxes.

Income Tax	38.73M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.19% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-44.19%
50-Day Moving Average	0.96
200-Day Moving Average	0.73
Relative Strength Index (RSI)	35.69
Average Volume (20 Days)	82

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cresco Labs had revenue of EUR 563.90 million and -44.48 million in losses. Loss per share was -0.13.

Revenue	563.90M
Gross Profit	269.91M
Operating Income	68.98M
Pretax Income	-4.45M
Net Income	-44.48M
EBITDA	113.18M
EBIT	68.98M
Loss Per Share	-0.13

Balance Sheet

The company has 38.71 million in cash and 494.98 million in debt, giving a net cash position of -456.28 million.

Cash & Cash Equivalents	38.71M
Total Debt	494.98M
Net Cash	-456.28M
Net Cash Per Share	n/a
Equity (Book Value)	289.93M
Book Value Per Share	1.02
Working Capital	123.81M

Cash Flow

In the last 12 months, operating cash flow was 63.87 million and capital expenditures -24.99 million, giving a free cash flow of 38.88 million.

Operating Cash Flow	63.87M
Capital Expenditures	-24.99M
Free Cash Flow	38.88M
FCF Per Share	n/a

Margins

Gross margin is 47.87%, with operating and profit margins of 12.23% and -7.89%.

Gross Margin	47.87%
Operating Margin	12.23%
Pretax Margin	-0.79%
Profit Margin	-7.89%
EBITDA Margin	20.07%
EBIT Margin	12.23%
FCF Margin	6.89%

Dividends & Yields

Cresco Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.55%
Shareholder Yield	-2.55%
Earnings Yield	-17.31%
FCF Yield	15.13%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cresco Labs has an Altman Z-Score of -0.47 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.47
Piotroski F-Score	5